EtiraRx
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3033 Irving Blvd, Dallas, Texas, 75247, ...Website
etira.lifeRevenue
<$5 MillionIndustry
About EtiraRx
EtiraRx Org Chart
Is EtiraRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if EtiraRx had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when EtiraRx launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at EtiraRx
Check if EtiraRx has recently received funding, and reach out quickly before it becomes old news!
Check out if EtiraRx is spiking on competitors!
EtiraRx, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once EtiraRx has new funding data
Earning: See what the market has to say on EtiraRx recently announced quarterly report
Recommended Actions
Find VP level buyers at EtiraRx
Find more new buyers
Company Profile Activity
Activity Insights
EtiraRx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EtiraRx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EtiraRx.
EtiraRx financials insights
Gather financial insights about EtiraRx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$2.3M
EtiraRx Tech Stack
A closer look at the technologies used by EtiraRx
EtiraRx News & Media
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EtiraRx
Operator of a biopharma research company intended to develop solutions to overcome tumor heterogeneity. The company advances novel cancer therapeutics validating molecular drivers of cancers to lead a systemic evaluation of mechanisms of therapy resistance to the development of novel therapeutics to treat cancers, helping patients plan for a future... Read More